Rebif vs Tecfidera (BG-12)

Rebif
(Rx)
Tecfidera (BG-12)
(Rx)
Rebif is a multiple sclerosis medication.
Tecfidera (BG-12) is a multiple sclerosis medication.
Satisfaction Score
?
2.4
Slightly Satisfied
Satisfaction Score
?
3.0
Moderately Satisfied
Helpfulness
for MS
2.3
Concern level
2.2
Helpfulness
for MS
2.5
Concern level
2.3
Approval Date
+ -
March 7, 2002
March 27, 2013
Number of discussions around the web Number of discussions + -
30,593 Discussions
10,257 Discussions
Taken For
+ -
Condition
Number of posts
#1 for MS
#2 for RRMS
#3 for SPMS
Rebif is prescribed for MS and is mostly mentioned together with this indication.
Condition
Number of posts
#1 for MS
#2 for RRMS
#3 for Psoriasis
Tecfidera (BG-12) is prescribed for MS and is mostly mentioned together with this indication.
Side Effects and Concerns
+ -
Reb
Tiredness
10
Flu Like Symptoms
8
Depression
7
Headaches
5
Flu
3
Bruise
3
Allergy
3
Itching
2
Anxiety
2
Fever
2
Tec
Progressive Multifocal Leukoencephalopathy
8
Nausea
5
Itching
4
Stomach Problems
2
Depression
2
Stomach Issues
2
Vomiting
2
Hair Loss
2
Rash
2
Burning
2
Compare concerns
By:
Rebif
Reb
Tecfidera (BG-12)
Tec
Tiredness
Reb
Tec
10
0
Flu Like Symptoms
Reb
Tec
8
0
Depression
Reb
Tec
7
2
Headaches
Reb
Tec
5
0
Flu
Reb
Tec
3
0
Bruise
Reb
Tec
3
0
Allergy
Reb
Tec
3
0
Itching
Reb
Tec
2
4
Anxiety
Reb
Tec
2
0
Fever
Reb
Tec
2
0
Progressive Multifocal Leukoencephalopathy
Tec
Reb
8
0
Nausea
Tec
Reb
5
0
Itching
Tec
Reb
4
2
Stomach Problems
Tec
Reb
2
0
Depression
Tec
Reb
2
7
Stomach Issues
Tec
Reb
2
0
Vomiting
Tec
Reb
2
0
Hair Loss
Tec
Reb
2
0
Rash
Tec
Reb
2
0
Burning
Tec
Reb
2
0
Pregnancy Category (FDA) OpenClose all pregnancy categories
+ -
a b c d x n
Category A
Adequate and well-controllted studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
Category B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category D
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category X
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Category N
FDA has not classified the drug.
close
C Category C
Before taking Rebif during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
C Category C
Before taking Tecfidera (BG-12) during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
Alcohol warning
+ -
There may be a negative interaction between Rebif and alcohol.
There may be a negative interaction between Tecfidera (BG-12) and alcohol.
Method of use
+ -
Injection
Pill
Dosages
+ -
Syringe: 22 mcg/0.5 mL, 44 mcg/0.5 mL
Capsule: 120 mg (14)- 240 mg (46), 120 mg, 240 mg
Food Instructions
+ -
No Food Instructions
No Food Instructions
Ingredients
+ -
Interferon Beta-1a/Albumin Human , Interferon Beta-1a
Dimethyl fumarate
Drug Interactions
+ -
Interaction between Rebif and Tecfidera (BG-12): Interaction not known, but may still exist. Always consult your doctor before taking these medications together. Do not stop taking the medications without a physician's advice.
Read more about:
Rebif
Read more about:
Tecfidera (BG-12)
content loaded dynamically
Filter by
Filter by
Gender
Role
Age
All
We found 805 discussions
Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice.
The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you.
The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information.
Welcome back! Sign in
See what other patients are saying
First time here? Sign up!
See what other patients are saying
Forgot your password?
No problem, we can help.
Please wait...